Fig 2.
(A). Post–external-beam radiation therapy patients with < 5% bone marrow blasts had overall survival (OS) superior to that of patients with ≥ 5% bone marrow blasts (P = .04). (B) In contrast, post–cytotoxic chemotherapy/combined-modality therapy patients with < 5% or ≥ 5% blasts had similar OS (P = .7).